GENinCode (LON:GENI) Shares Down 2.1% – What’s Next?

GENinCode Plc (LON:GENIGet Free Report) dropped 2.1% on Thursday . The company traded as low as GBX 4 ($0.05) and last traded at GBX 4.02 ($0.05). Approximately 90,092 shares traded hands during trading, a decline of 92% from the average daily volume of 1,074,552 shares. The stock had previously closed at GBX 4.10 ($0.05).

GENinCode Trading Down 2.2 %

The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.27. The stock has a 50-day simple moving average of GBX 3.86 and a two-hundred day simple moving average of GBX 5. The firm has a market capitalization of £6.66 million, a P/E ratio of -75.32 and a beta of 0.66.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Read More

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.